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Abstract
AIM: To investigate the immunological repertoire in the 
peritoneal cavity of gastric cancer patients.
METHODS: The peritoneal cavity is a compartment 
in which immunological host-tumor interactions can 
occur. However, the role of lymphocytes in the peri-
toneal cavity of gastric cancer patients is unclear. We 
observed 64 patients who underwent gastrectomy for 
gastric cancer and 11 patients who underwent lapa-
roscopic cholecystectomy for gallstones and acted as 
controls. Lymphocytes isolated from both peripheral 
blood and peritoneal lavage were analyzed for surface 
markers of lymphocytes and their cytokine production 
by flow cytometry. CD4+CD25high T cells isolated from 
the patient’s peripheral blood were co-cultivated for 4 
d with the intra-peritoneal lymphocytes, and a cytokine 
assay was performed. 
RESULTS: At gastrectomy, CCR7- CD45RA- CD8+ ef-
fector memory T cells were observed in the peritoneal 
cavity. The frequency of CD4+ CD25 high T cells in both 
the peripheral blood and peritoneal cavity was el-
evated in patients at advanced stage [control vs  stage 
Ⅳ in the peripheral blood: 6.89 (3.39-10.4) vs  15.34 
(11.37-19.31), P  < 0.05, control vs  stage Ⅳ in the peri-
toneal cavity: 8.65 (5.28-12.0) vs  19.56 (14.81-24.32), 
P  < 0.05]. On the other hand, the suppression was 
restored with CD4+ CD25high T cells from their own pe-
ripheral blood. This study is the first to analyze lympho-
cyte and cytokine production in the peritoneal cavity in 
patients with gastric cancer. Immune regulation at ad-
vanced stage is reversible at the point of gastrectomy.
CONCLUSION: The immunological milieu in the peri-
toneal cavity of patients with advanced gastric cancer 
elicited a Th2 response even at gastrectomy, but this 
response was reversible.
© 2012 Baishideng. All rights reserved.
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INTRODUCTION
Tumor progression is governed not only by the genetic 
changes intrinsic to cancer cells, but also by epigenetic 
and environmental factors. Therefore, neoplastic cell 
factors and biophylactic side factors such as immune 
reactions are interacting in the survival and development 
of  micrometastasis. Increasing evidence gleaned from 
studies in immune-compromised hosts suggests that the 
cellular mechanisms of  immunosurveillance influence 
tumor development. There are several lines of  research 
which indicate the critical role of  the immune system in 
controlling the growth of  malignant cells[1-5]. Thus, im-
pairment of  anti-tumor immunity, which leads to immu-
nologic toleration of  malignant cells, contributes to the 
development and progression of  peritoneal metastasis[6]. 
The elimination phase of  the cancer immunosurveillance 
mechanism is thought to be a continuous process, and lo-
cal control of  metastatic invasion by the immune system 
may be critical for survival. However, the role of  lympho-
cytes in the peritoneal cavity for anti-tumor immunity in 
gastric cancer patients is unknown[7]. 
Studies in rodents have demonstrated that adoptive 
immunotherapy with antigen-specific CD8+ T cells is 
effective for cancer, and there is evidence that this ap-
proach has therapeutic activity in humans[8-10]. Memory T 
cells circulate throughout all tissues of  the body and are 
primed to rapidly produce secondary immune responses 
upon antigen challenge[11]. The nature of  the cells that 
mediate the different facts of  immunological memory 
remains unresolved. Natural killer T cells are a specialized 
subset of  T cells. They express T-cell and natural killer-
lineage cell surface markers and key cytokines, which 
regulate the course of  the immune response. There are 
many mechanisms that regulate and dampen the im-
mune response to cancers[12-15]. Regulatory T cells protect 
the host from autoimmune disease by suppressing self-
reactive immune cells. As such, regulatory T cells may 
also block antitumor immune responses. Regulatory T 
cells have been an active research area in basic as well as 
in clinical immunology[16-18]. Th1 immune responses are 
considered to be essential for eradicating malignant cells. 
Based on the cytokine profile, interferon-gamma is a Th1 
cytokine with an antitumor effect. Interleukin-10, a Th2 
cytokine, inhibits Th1 immune responses and enhances 
the production of  other Th2 cytokines[19-22]. 
 In order to clarify the clinical significance of  the host 
immune response within the peritoneal cavity in patients 
with gastric cancer, we conducted an immunological anal-
ysis of  the peritoneal lavage obtained from patients at the 
time of  gastrectomy.
MATERIALS AND METHODS
Patients
A total of  75 patients (50 males and 25 females; mean age: 
64.3 years) were included in this study. Sixty-four patients 
were histologically diagnosed as having gastric cancer. 
Among these, 56 had gastrectomy, 2 underwent bypass op-
eration, and 6 had exploratory laparotomy. Eleven patients 
who underwent laparoscopic cholecystectomy for benign 
disease acted as controls. The resected specimens were 
histologically examined by hematoxylin and eosin staining 
according to the general rules of  the Japanese Classification 
of  Gastric Carcinoma[23]. The investigation protocol was 
approved by the Institutional Review Board of  the Naga-
saki University School of  Medicine (#14122694). Written 
informed consent was obtained from all patients. The 
stages of  gastric cancer patients were as follows: stage Ⅰ
A, n = 25 patients; stage ⅠB, n = 13; stage Ⅱ, n = 7; stage 
Ⅲ, n= 7; and stage Ⅳ, n = 12. The clinicopathological 
features of  the patients are shown in Table 1. 
Isolation of mononuclear cells from peripheral blood 
and peritoneal lavage
Endotracheal general anesthesia was induced and 10 mL 
of  peripheral blood was taken from all patients. Four 
hundred milliliter of  physiological saline was poured into 
the peritoneal cavity prior to manipulation of  the tumor, 
and was recovered after being gently stirred. Half  of  the 
peritoneal lavage was allocated for conventional cytol-
ogy and carcinoembryonic antigen (CEA) analysis by an 
enzyme-linked immunosorbent assay. The other half  of  
the peritoneal lavage was immediately centrifuged at 2000 
rpm for 10 min, and the supernatants were assayed for 
CEA values. The peritoneal CEA levels were then mea-
sured using an enzyme immunoassay kit (IMx-SERECT 
CEA, Dainabot, Tokyo) and the protein concentration 
was determined using a protein assay kit (Bio-Rad, Rich-
mond, CA, United States). The cell component was used 
for lymphocyte analysis. Lymphocytes from peripheral 
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Table 1  Clinicopathological features in the examined gastric 
cancer patients
Variables No. of patients
Total cases  64
Age (yr) 67.5 ± 2.8
Sex (male/female) 42/22
Depth of tumor invasion    
   T1 32
   T2 20
   T3   9
   T4   3
Lymphnode metastasis
   N0 34
   N1 12
   N2 14
   N3   4
Peritoneal metastasis
   Absent 56
   Present   8
Cytology 
   Negative 57
   Positive   7
Stage
   Stage ⅠA 25
   Stage ⅠB 13
   Stage Ⅱ   7
   Stage Ⅲ   7
   Stage Ⅳ 12
blood were isolated by density centrifugation over Ficoll-
PaqueTM gradients (Amersham, Uppsala, Sweden).
Flow cytometry
The following monoclonal antibodies were used in the 
present study: fluorescein isothiocyanate (FITC)-conjugat-
ed anti-CD8, FITC-CD25, FITC-CD45RA, phycoerythrin 
(PE)-conjugated anti-CD4, PE-CD56, PE-CCR7, PE-
IFN-γ, PE-IL-10, PE-Foxp3, cychrome (Cy)-conjugated 
anti-CD3, and Cy-CD8 (BD Pharmingen, San Diego, 
CA, United States). Single-cell suspensions were stained 
in phosphate-buffered saline-1% fetal calf  serum at satu-
rating concentrations according to standard procedures. 
Flow cytometry was performed on the BD Biosystems-
FACSCanto Ⅱ system (BD Biosciences, San Diego, CA, 
United States), and FACSDiva software (BD Biosciences, 
San Diego, CA, United States) was used for analysis. All 
analyses of  T cells were carried out after gating by CD3. 
The ratio of  the percentage of  CD4 and CD8 cells was 
represented as the CD4/CD8 ratio.
Intracellular staining for Foxp3
Intracellular staining for Foxp3 was performed using the 
Human Foxp3 Buffer set (BD Pharmingen, San Diego, CA, 
United States) according to the manufacturer’s protocol.
Cytokine assays
Anti-IFN-γ-PE and anti-IL-10-PE mAbs were used for 
the intracellular analysis of  cytokine production. Pe-
ripheral and intra-peritoneal lymphocytes were activated 
with 10 ng/mL phorbol 12-myristate-13-acetate (PMA), 
0.5 μg/mL Ionomycin, and 1 μL/mL GolgiPlug (BD 
Pharmingen, San Diego, CA, United States) for 4 h. Cells 
were washed, fixed and permeabilized by Cytofix/Cy-
toperm solution (BD Pharmingen, San Diego, CA, Unit-
ed States), and stained with titrated amounts of  cytokine-
specific antibodies.
Next, the CD4+ CD25 + T cells were isolated from 
peripheral blood by magnetic beads (Miltenyi Biotech,Be
rgischGladbach, Germany). These CD4+ CD25 + T cells 
were mixed with intraperitoneal lymphocytes at a ratio of  
1:10 and co-cultivated for 4 d in RPMI with 10% FBS. 
The CD4+ CD25- T cells were co-cultivated with intra-
peritoneal lymphocytes as controls. The cytokine assay 
was performed by the intracellular cytokine method after 
4 d of  co-cultivation. 
Statistical analysis
The statistical analysis was performed using the Kruskal-
Wallis test (non-parametric ANOVA) using a personal 
computer and the StatViewV.5.0 software package (SAS 
Institute, Cary, NC, United States). P values less than 0.05 
were considered to indicate statistical significance.
RESULTS
Carcinoembryonic antigen values in sera and peritoneal 
lavage 
For the interaction between peripheral blood and the 
peritoneal cavity, we investigated the CEA values in both 
serum and peritoneal lavage at the time of  surgery. The 
serum CEA values were elevated only in patients with 
stage Ⅳ disease. On the other hand, the values in peri-
toneal lavage were found to be elevated even at stage Ⅲ, 
and they were also related to the clinical stage (Table 2).
Analysis of lymphocyte populations in peripheral blood 
and the peritoneal cavity 
After purification of  lymphocytes from peritoneal lavage, 
we investigated the phenotypes of  lymphocytes in both 
peripheral blood and the peritoneal cavity. The mean 
value of  the CD4/CD8 ratio for all patients was 2.17 in 
peripheral blood. The CD8+ T cells were dominant in the 
peritoneal cavity and the CD4/CD8 ratio was reversed. 
The ratio in patients with stage Ⅲ or Ⅳ was significantly 
higher than in stage Ⅰ or control patients (Table 2).
The CCR7- CD45RA- CD8+ T cells were counted as 
effector memory T cell subsets. The percentage of  ef-
fector memory T cells in the peritoneal cavity was higher 
than that in peripheral blood. However, the percentage 
1472 April 7, 2012|Volume 18|Issue 13|WJG|www.wjgnet.com
Table 2  Carcinoembryonic antigen values in sera and peritoneal lavage
Source Control Stage Ⅰ A Stage Ⅰ B Stage Ⅱ Stage Ⅲ Stage Ⅳ
CEA
   PB (ng/mL) Not tested 2.09 (1.39-2.78)        2.03 (0.96-3.1) 3.06 (2.04-4.07) 2.54 (0.38-4.69)   7.98 (1.18-15.82)
   PL (ng/g protein) 56.53 (21.82-91.24)   44.17 (27.37-60.96)     61.95 (11.98-111.91)   83.14 (7.31-187.54) 262.63 (7.26-517.26)   1234.00 (87.77-2380.22)
CD4/CD8 
   PB (ratio) 5.379 (2.705-8.052)   5.595 (3.224-7.967)   4.571 (2.057-7.086)   5.277 (1.369-9.184)     7.999 (3.366-12.632)   4.156 (2.228-6.083)
   PL (ratio) 0.494 (0.338-0.649)   0.553 (0.421-0.685)   0.697 (0.511-0.883)   0.638 (0.395-0.881)   1.242 (0.961-1.522)   1.158 (0.907-1.408)
CD45RA-/CCR7-
   PB (%) 60.43 (46.42-74.44)   58.29 (48.93-67.64) 53.92 (32.65-75.2)   57.36 (42.01-72.71)   49.01 (29.31-68.71)   45.73 (32.79-58.67)
   PL (%) 81.17 (81.12-93.22)   81.67 (76.35-87.01)     76.2 (59.43-92.96)     72.3 (61.01-83.58)   68.36 (58.70-78.02)   51.92 (38.34-65.50)
NKT 
   PB (%) 9.19 (5.83-12.54) 7.59 (5.63-9.56)   9.47 (4.41-14.53) 10.71 (1.55-19.87)   5.43 (0.54-10.33) 7.16 (3.95-10.3)
   PL (%) 18.1 (9.83-26.37)   17.25 (13.54-20.97) 15.74 (9.23-22.25) 15.38 (7.71-23.04) 9.66 (1.2-18.11)   9.91 (6.94-12.88)
PB: Peripheral blood; PL: Peritoneal lavage; CI: Confidence interval. The data are presented as the median and 95% CI. The statistical analysis of the 
differences revealed higher CEA and CD4/CD8, lower CD8+ effector memory T cells and NKT cells in the peritoneal cavity in patients with advanced stage 
than in controls. 
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CD25- cells (Figure 4B). 
DISCUSSION
The peritoneal cavity is a compartment in which the im-
munological host-tumor interaction can occur[24]. This 
study investigated lymphocytes in the peritoneal cavity 
of  patients with gastric cancer in relation to anti-tumor 
immunity. Some tumors can acquire the ability to down-
regulate immune responses and exploit this action to pro-
mote tumor cell proliferation, survival, and invasion[10,25]. 
Therefore, the presence of  leukocytes in the peritoneal 
cavity may be a consequence of  an immune response 
that favors either dissemination of  tumor cells or a pro-
tective host response. Malignant ascites has been used as 
a common source of  immunological analysis in previous 
reports[11,26]. To the best of  our knowledge, there are no 
reports describing the lymphocyte and cytokine produc-
tion ability in peritoneal lavage from patients with gastric 
cancer at the time of  gastrectomy. 
In our initial experiments, the CEA values in peri-
toneal lavage were found to correlate with the clinical 
stages. Interestingly, the CEA values were elevated even 
in cases without serosal invasion. This result suggests that 
some fragments of  cancer cells may spread throughout 
the peritoneal cavity and induce an immune reaction be-
tween the tumor and host[26,27]. 
The frequency of  CD4+ T cells in all patients was 
higher than that of  CD8+ T cells in peripheral blood, but 
this pattern was reversed in peritoneal lavage fluid. CD8+ 
T cells were dominant in the peritoneal cavity. Our data 
suggested that the immunological environment in the 
peripheral blood is different from that in the peritoneal 
cavity. There were significant differences in the CD4/
CD8 ratio in the peritoneal cavity between gastric cancer 
decreased in association with the clinical stage (Table 2). 
The CD3+CD56+ cells were measured as natural killer 
T cells. The percentage of  these cells in the peritoneal 
lavage was also low in patients with stage Ⅲ or stage Ⅳ 
(Table 2). As the co-staining of  foxp3 and CD25 revealed 
a high correlation between both populations, CD25high 
was used following cytokine producing assays (Figure 1). 
The frequency of  CD4+ CD25 high T cells in patients with 
advanced stage cancer was higher than that in control pa-
tients in both peripheral blood and the peritoneal cavity 
(Figure 2A and B). 
Cytokine production by lymphocytes 
The cytokine production from CD3+ T cells after stimu-
lation with PMA + ionomycin was evaluated by a cyto-
kine production assay. The lymphocytes in the peritoneal 
cavity were more sensitive for the production of  IFN-γ 
than those in the peripheral blood. The ratio of  IFN-γ 
producing cells in the peritoneal cavity was significantly 
lower in patients with advanced stage disease in compari-
son to the controls (Figure 3A and B). The ratio of  IL-10 
producing cells in the peritoneal cavity in patients with 
advanced stages was higher in comparison to the controls 
(Figure 3C and D). 
Cytokine assays of intra-peritoneal lymphocytes after 
co-cultivation with self- CD4+CD25 high T cells
In order to investigate whether the suppression of  IFN-γ 
production from T cells in the peritoneal cavity at ad-
vanced stages was caused by CD4+ CD25high T cells, fur-
ther assays were performed. The IFN-γ production of  
CD8+ T cells was suppressed in intra-peritoneal lympho-
cytes co-cultivated with isolated CD4+ CD25high T cells 
from self-peripheral blood (Figure 4A). No inhibition was 
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Figure 1  Co-staining with foxp3 and CD25 for CD4+ T cells. High correlation was shown between both populations. 
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patients at advanced stage and control patients. Cancer 
progression may have an effect on the balance of  the T 
cell population in the peritoneal cavity.
Immunological memory is demonstrated by following 
T cell subsets: lymph-node-homing cells lacking inflam-
matory and cytotoxic function (defined as central mem-
ory T cells, CCR7+ CD45RA-) and tissue-homing cells 
endowed with various effector functions (defined as ef-
fector memory T cells, CCR7- CD45RA-). These two sub-
sets allow for the division of  labor among memory cells. 
Effector memory T cells represent a readily available pool 
of  antigen-primed cells that can enter peripheral tissues 
to mediate inflammatory reactions or cytotoxicity, thus 
rapidly containing invasive pathogens and cancer anti-
gens[11,28-31]. Our data show that CD8+ effector memory T 
cells were rich in the peritoneal cavity. This indicates the 
migration of  effector memory cells from the peripheral 
blood to local sites. However, in advanced cases, the fre-
quency of  CD8+ effector memory cells in the peritoneal 
lavage was low. These results suggest that the peritoneal 
cavity exerts the local immune response, more than pe-
ripheral blood.
Natural killer T cells, a unique lymphocyte subpopula-
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Figure 2  Analysis of lymphocyte populations in peripheral blood and the peritoneal cavity. A: The gating and counting of CD4+ CD25high T cell population by 
flow cytometry; B: The percentage of CD4+ CD25high T cells in the CD4+ T cell population in peripheral blood and peritoneal lavage of patients at each stage of gastric 
cancer and control patients. Data are presented as the mean ± SD. 
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Figure 3  Cytokine production by lymphocytes. A: The gating and counting of the IFN-γ producing cell population by flow cytometry; B: The percentage of IFN-γ produc-
ing cells in the CD3+ cell population stimulated with PMA + ionomycin in peripheral blood and peritoneal lavage of patients at each stage of gastric cancer and control patients 
Data are presented as the mean ± SD. The statistical analysis was performed by the Kruskal-Wallis test. After gating of CD3+ T cells, 10  000 events were analyzed. The 
production of IFN-γ in the peritoneal cavity was higher than that in the peripheral blood. The ratio of IFN-γ production cells in the peritoneal lavage was significantly lower 
in patients with advanced-stage than in controls [control vs stage Ⅳ: 51.1 (35.1-67.1) vs 10.7 (2.6-22.1), aP < 0.05]; C: The gating and counting of the IL-10 producing cell 
population by flow cytometry; D: The percentage of IL-10 producing cells in the CD3+ cells stimulated with PMA + ionomycin in peripheral blood and peritoneal lavage of 
patients at each stage of gastric cancer and control patients. Data are presented as the mean ± SD. The ratio of IL-10 producing cells in peripheral blood and intra-peritoneal 
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tigen receptors[12,13]. Natural killer T cells have been sug-
gested to serve as a bridge between innate and acquired 
immunity[14,15]. However, the mechanisms underlying the 
anti-tumor effect of  human natural killer T cell-mediated 
immunotherapy remain unclear so far. The frequency of  
natural killer T cells was lower in patients with stages Ⅲ 
and Ⅳ than in control patients. Therefore, a decrease in 
the number of  natural killer T cells in the peritoneal cav-
ity may be one aspect of  the interaction between host-
immunity and cancer progression. 
Recent studies have shown that CD4+ CD25high foxp3+ 
T cells exhibiting regulatory/suppressive properties are 
naturally present in humans[16-18]. The roles of  regulatory 
T cells have been active topics of  research in both basic 
and clinical immunology. Naturally-occurring regula-
tory T cells represent a small fraction (5%-6%) of  the 
overall CD4+ T cell population, and play an important 
role in down-regulation of  the response of  T cells to 
foreign and self  antigens[31]. The depletion of  this subset 
of  regulatory T cells in normal hosts results in various 
autoimmune diseases because the host immune system is 
unchecked and attacks the body’s own tissues[28]. Despite 
the importance of  these cells in preventing autoimmune 
disease, their presence in the tumor microenvironment 
diminishes anti-tumor immune responses[32-36].
Within the CD4+ T cell subset, there is a population of  
naturally occurring foxp3+ T cells that are defined as regula-
tory T cells. These cells can be identified as CD4+foxp3+ 
T cells by flow cytometry. However, because foxp3 is 
intracellular and requires permeabilization of  cells for 
detection by flow cytometry, regulatory T cells are iso-
lated as CD4+CD25high T cells, which were shown to 
have functional suppressive abilities in our co-culture 
experiments[37]. In the present study, the mean percent-
age of  CD4+ CD25high T cells in the peritoneal cavity in 
advanced gastric cancer patients was higher than that 
of  control patients. After the co-cultivation of  the self- 
CD4+ CD25high T cell population of  intra-peritoneal 
lymphocytes, the production of  IFN-γ was inhibited. 
IFN-γ, a Th1 cytokine, not only exerts an anti-tumor 
effect, but also inhibits the proliferation of  Th2 clones[19-20]. 
IL-10, a Th2 cytokine, suppresses the synthesis of  Th1 
cytokines such as IFN-γ[21-22]. This study showed that the 
production of  intracellular cytokines in the peritoneal 
cavity was higher than that in the peripheral blood after 
appropriate stimulation. IFN-γ production was down-
regulated in advanced cases, but not in the controls and 
stage Ⅰ patients. On the other hand, IL-10 production 
was up-regulated, which revealed the switch of  Th1 and 
Th2 responses in the peritoneal cavity of  these patients. 
IFN-γ production in intra-peritoneal lymphocytes was 
suppressed after co-cultivation with self-CD4+ CD25high 
T cells, but not CD4+ CD25- T cells. Interestingly, the 
replacement of  CD4+ CD25- T cells for CD4+ CD25high 
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Research frontiers
Clinical and experimental studies have established that leukocyte infiltrations 
around tumors promote the development or regression of solid tumors, but-
whether the organ-specific cellular and molecular programs promote tumor 
growth or exhibit anti-tumor immunity by leukocytes are incompletely under-
stood. Recent studies have shown that CD4+ CD25high foxp3+ T cells exhibiting 
regulatory/suppressive properties are naturally present in humans. The roles of 
regulatory T cells have been active topics of research in both basic and clinical 
immunology. 
Innovations and breakthroughs
In most previous studies, malignant ascites have been a common source of im-
munological analysis. However, there are no reports describing the lymphocyte 
and cytokine production ability in peritoneal lavage from patients with gastric 
cancer at the time of gastrectomy. In the present study, CD4+ CD25high T cells 
were found to be increased in the peritoneal cavity of advanced gastric cancer 
patients, but in the co-cultivation of the self- CD4+ CD25high T cell population of 
intra-peritoneal lymphocytes, the production of IFN-γwas inhibited.
Applications
Peritoneal lavage samples from patients with gastric cancer are more suscep-
tible than peripheral blood for monitoring the interaction between the host’s 
immune system and tumor cells. 
Terminology
Regulatory T cells: Regulatory T cells contribute to the maintenance of immuno-
logic self-tolerance. Recent reports underscore that regulatory T cells not only 
play a role in the maintenance of immunotolerance but are also potent inhibitors 
of antitumor immune responses. 
Peer review
The authors have investigated T-cells isolated from peripheral blood and perito-
neal lavage in patients with gastric cancer and controls. Main findings are that 
in stage Ⅲ and Ⅳ gastric cancers the lavage fluid contains less CD8 memory 
cells, NKT cells and more CD25high regulatory T cells.
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